Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.

MLA

DeFilipp, Z., et al. “Metabolic Syndrome and Cardiovascular Disease Following Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from CIBMTR and EBMT.” Bone Marrow Transplantation, vol. 52, no. 2, Feb. 2017, pp. 173–82. EBSCOhost, https://doi.org/10.1038/bmt.2016.203.

APA

DeFilipp, Z., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D. M., Miranda, J. L., Arat, M., Baker, K. S., Burns, L. J., Duncan, C. N., Gilleece, M., Hale, G. A., Hamadani, M., Hamilton, B. K., Hogan, W. J., Hsu, J. W., Inamoto, Y., Kamble, R. T., Lupo-Stanghellini, M. T., … Shaw, B. E. (2017). Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplantation, 52(2), 173–182. https://doi.org/10.1038/bmt.2016.203

Chicago

DeFilipp, Z, R F Duarte, J A Snowden, N S Majhail, D M Greenfield, J L Miranda, M Arat, et al. 2017. “Metabolic Syndrome and Cardiovascular Disease Following Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from CIBMTR and EBMT.” Bone Marrow Transplantation 52 (2): 173–82. doi:10.1038/bmt.2016.203.